Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | CASP3 | P42574 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | AGPAT2 | O15120 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10829015 | 0.89 | MAOB (0.52) | MEN1KMT2AMAPTANO1NPSR1 | |
| SCHEMBL11197714 | 0.84 | KMT2A (0.51) | MEN1KMT2AMAPTNPSR1XDH | |
| SCHEMBL11347687 | 0.83 | PARP3 (0.51) | MEN1KMT2AMAPTNPSR1XDH | |
| SCHEMBL11170471 | 0.82 | RAB9A (0.48) | KMT2AMAPTNPSR1XDHTP53 | |
| SCHEMBL11161951 | 0.81 | DAGLA (0.51) | MEN1KMT2AMAPTXDHPOLB | |
| SCHEMBL11077235 | 0.81 | TP53 (0.46) | MEN1KMT2AMAPTANO1NPSR1 | |
| SCHEMBL11166473 | 0.79 | MAPT (0.47) | MAPTXDHTP53POLBALOX15 | |
| SCHEMBL11163100 | 0.79 | HTT (0.42) | MEN1KMT2AMAPTTP53MAOB | |
| SCHEMBL10829024 | 0.79 | MAPT (0.56) | MEN1KMT2AMAPTANO1NPSR1 | |
| SCHEMBL10477441 | 0.77 | CASP3 (0.43) | MEN1KMT2AMAPTANO1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119004017-A | Method and system for intelligently regulating and controlling thallus structure for edible fungus strain production | 汉中聚农源农业科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| CN-118777308-A | Method and system for plate shape characterization and defect analysis judgment after steel plate quenching | 陈俊康 | 2024-10-15 | — | — | CN | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-8268352-B2 | Modified release composition for highly soluble drugs | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-18 | — | — | US | claimed |
| US-8263125-B2 | Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients | TORRENT PHARMACEUTICALS LIMITED (IN) | 2012-09-11 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-20060024365-A1 | Novel dosage form | VAYA NAVIN | 2006-02-02 | — | — | US | claimed |
| US-20060018933-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| US-20060018934-A1 | Novel drug delivery system | TORRENT PHARMACEUTICALS LIMITED (IN) | 2006-01-26 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| EP-0327052-A2 | Use of quinoline derivatives for making a medicament effective in the prevention and treatment of ulcers | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-08-09 | — | — | EP | claimed |
| US-4831040-A | (IMIDAZOLO-, THIAZOLO-, OXAZOLO-)(4,5-H)-QUINOLINE | RORER PHARMACEUTICAL CORPORATION (US) | 1989-05-16 | — | — | US | claimed |
| US-4620010-A | Process for preparing carboalkoxy substituted benzoxazole compounds | USV PHARMACEUTICAL CORP. (US) | 1986-10-28 | — | — | US | claimed |
| EP-0039919-B1 | BENZOXAZOLE AND BENZOTHIAZOLE DERIVATIVES WITH ANTI-ALLERGIC ACTIVITY | USV PHARMACEUTICAL CORPORATION (US) | 1983-12-28 | — | — | EP | claimed |
| EP-0039919-A1 | Benzoxazole and benzothiazole derivatives with anti-allergic activity | USV PHARMACEUTICAL CORPORATION (US) | 1981-11-18 | — | — | EP | claimed |
| US-4298742-A | ANTIALLERGENS | USV PHARMACEUTICAL CORPORATION (US) | 1981-11-03 | — | — | US | claimed |